[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
作者信息
Schwartz P J
机构信息
Cattedra di Cardiologia, Università degli Studi, Policlinico San Matteo IRCCS, Pavia.
出版信息
Cardiologia. 1996 Aug;41(8):739-45.
PMID:8925528
Abstract
摘要
相似文献
1
2
[Role of antiarrhythmics in the post-infarction period].
Arch Mal Coeur Vaiss. 2000 Apr;93(3 Spec No):65-9.
3
[The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].胺碘酮与β受体阻滞剂联合使用可能是对有猝死风险患者的一种替代治疗方法，在这类患者中，植入式除颤器的益处尚未得到明确证实。
Ital Heart J Suppl. 2002 Mar;3(3):337-43.
4
Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.β-肾上腺素能阻滞剂提高心室颤动阈值。
Arch Int Pharmacodyn Ther. 1972 Dec;200(2):292-300.
5
[Improved prognosis using beta blockers after myocardial infarct?].
Lebensversicher Med. 1984 Jan 1;36(1):14-9.
6
Cardiac death prevention in post-myocardial infarction patients: a review.
Acta Cardiol Suppl. 1980(25):147-79.
7
[Secondary prevention of myocardial infarct].
Vutr Boles. 1984;23(2):55-9.
8
[Anti-arrythmic effects of DL-propranolol, D-propranolol and I.C.I.50 172 in experimental myocardial infarction in dogs].
Acta Physiol Pol. 1970 May-Jun;21(3):317-29.
9
Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
J Am Coll Cardiol. 2009 Aug 11;54(7):616-7. doi: 10.1016/j.jacc.2009.05.020.
10
[Nifedipine in the therapy of myocardial infarct in patients over 70].[硝苯地平用于70岁以上患者心肌梗死的治疗]
Minerva Cardioangiol. 1982 Apr;30(4):163-9.
引用本文的文献
1
Pharmacological interventions for heart failure in people with chronic kidney disease.慢性肾脏病患者心力衰竭的药物干预措施。
Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2.
Zotero 插件